Haojie Shan | Medicine | Best Researcher Award

Haojie Shan | Medicine | Best Researcher Award

Resident Surgeon at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School, China.

Dr. Haojie Shan is a dedicated resident surgeon specializing in orthopaedics at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With a strong clinical and research foundation, Dr. Shan is passionate about advancing orthopaedic treatments, focusing on challenging areas such as osteonecrosis of the femoral head, bone immunity, and regeneration. His contributions to orthopaedics have been recognized through multiple prestigious awards, highlighting his commitment to innovation. Dr. Shan’s blend of clinical expertise and research excellence positions him as an emerging leader in orthopaedics, driven to enhance patient care and develop novel medical solutions.

Publication Profile

Scopus

Education

Dr. Shan completed his Ph.D. in Surgery (Orthopaedics) in 2023 at Shanghai Jiao Tong University, where he also earned his MD in 2020. He first obtained his Bachelor of Science in Clinical Medicine from Henan University in 2017. Each stage of his education has been marked by rigorous training, both in clinical practice and research, equipping him with a comprehensive understanding of orthopaedic medicine. This academic progression underscores Dr. Shan’s commitment to mastering complex medical challenges, particularly in his chosen field of orthopaedics, and provides a strong foundation for his clinical and research career.

Professional Experience

Currently, Dr. Shan is a resident surgeon in orthopaedics at Shanghai Sixth People’s Hospital. In this role, he has gained practical experience managing complex orthopaedic cases, with a focus on surgical techniques and postoperative care. His position at this leading hospital allows him to integrate his research insights with clinical practice, enhancing patient care with innovative approaches. His exposure to diverse cases has refined his skills in addressing issues like bone regeneration and infection control, which align with his research interests. Dr. Shan’s experience exemplifies his dedication to combining clinical expertise with research-driven improvements in orthopaedic care.

Research Focus

Dr. Shan’s research focuses on osteonecrosis of the femoral head, bone immunity, bone regeneration, and biomedical materials. His work seeks to address significant challenges in orthopaedic surgery, such as restoring bone function and preventing infection in complex cases. Dr. Shan is particularly interested in innovative treatments that promote healing and enhance patient outcomes. His research on bone and soft tissue infection and immunity explores the interactions between implants and the body’s immune response. Through his investigations, Dr. Shan aims to bridge scientific discovery and clinical application, advancing orthopaedic treatment methods and expanding therapeutic options in the field.

Awards and Honors

Dr. Shan has received multiple prestigious awards, reflecting his contributions to orthopaedics and medical innovation. In 2024, he won the Gold Award in the Shanghai Division and the National Silver Award at the International Innovation Competition for College Students in China. Additionally, he earned First Prize in the Rehabilitation Medicine and Engineering Innovation Competition (2023) and accolades for his papers at major conferences. His achievements also include third-place awards in the China Medical Device Innovation Competition and the Shanghai Orthopedics Annual Meeting. These recognitions underscore Dr. Shan’s dedication to advancing orthopaedic science and patient care.

Conclusion

Overall, Dr. Haojie Shan demonstrates strong qualifications for the “Best Researcher Award” based on his academic background, innovative research, and significant recognition within orthopaedics. Enhancing international visibility through collaborations and publications could further elevate his standing. Given his notable achievements and ongoing impact, he is a well-qualified candidate for the award.

Publication Top Notes 

Title: A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm
Authors: Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X.
Year: 2025
Journal: Carbohydrate Polymers, 347, 122723
Citations: 0

Title: Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections
Authors: Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X.
Year: 2024
Journal: Aggregate
Citations: 0

Title: An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing
Authors: Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C.
Year: 2024
Journal: Small Methods
Citations: 0

Title: Scd-1 deficiency promotes the differentiation of CD8+ T effector
Authors: Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X.
Year: 2024
Journal: Frontiers in Cellular and Infection Microbiology, 14, 1325390
Citations: 1

Title: Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways
Authors: Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X.
Year: 2023
Journal: Cell Proliferation, 56(11), e13485
Citations: 4

Title: Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α
Authors: Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T.
Year: 2023
Journal: Advanced Therapeutics, 6(3), 2200164
Citations: 2

Title: The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis
Authors: Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(4), pp. 240–245
Citations: 0

Title: Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination
Authors: Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(3), pp. 197–203
Citations: 0

Title: Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis
Authors: Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X.
Year: 2022
Journal: mSystems, 7(4)
Citations: 9

 

Mohsen Sheykhhasan | Medical Biotechnology | Best Researcher Award

Dr Mohsen Sheykhhasan |  Medical Biotechnology |  Best Researcher Award

Researcher at  Qom University of Medical Sciences, Iran

Mohsen Sheykhhasan is a distinguished researcher affiliated with the Cellular and Molecular Research Center at Qom University of Medical Sciences, Qom, Iran. He holds a Bachelor’s degree in Plant Breeding from the University of Shahed, a Master’s degree in Agricultural Biotechnology from the University of Mazandaran, and a Ph.D. in Medical Biotechnology from Hamadan University of Medical Sciences. Dr. Sheykhhasan’s research spans various projects involving mesenchymal stem cells, exosome therapy, and gene expression.

Profile

Education 🎓

  • Bachelor of Plant Breeding
    University of Shahed, Iran (2002-2006) – Overall G.P.A: 14.96 (B)
  • Master of Agricultural Biotechnology
    University of Mazandaran, Iran (2007-2009) – Overall G.P.A: 17.48 (A)
  • PhD in Medical Biotechnology
    Hamadan University of Medical Sciences, Iran (2017-2022) – Overall G.P.A: 17.62 (A)

Awards and Honors 🏅

  • Appreciation certificate from the Vice President of Qom University of Medical Sciences (2019)
  • 2nd rank in overall G.P.A among MSc Biotechnology students (2009)
  • Scholar Student certificate from the Head of the Department of Medical Biotechnology, Hamadan University of Medical Sciences
  • Article selected as “Reader’s Choice” in Cancer Gene Therapy (2022)
  • Scopus H-Index: 18
  • Google Scholar H-Index: 19
  • Peer-reviewed 570 papers for prestigious journals

Professional Experience 🧑‍🔬

  • Research Assistant
    Department of Mesenchymal Stem Cells, ACECR, Qom Branch, Qom, Iran (May 2013 – January 2023)

    • Projects on exosomes, breast cancer, endometriosis, Crohn’s disease, and more
  • Lab Technician and Coordinator
    Department of Mesenchymal Stem Cells, ACECR, Qom Branch, Qom, Iran (June 2013 – October 2023)
  • Research Assistant
    Agricultural Biotechnology Research Institute of Iran, Karaj, Iran (September 2007 – December 2009)

    • Transformation and Light Inducible Expression of cry1Ab Gene in Oilseed Rape (Brassica napus L.)
  • University Lecturer
    Science Applied University, Qom, Iran (November 2010 – April 2012)

    • Taught courses on tissue culture and plant biotechnology
  • Teacher Assistant
    University of Qom, Qom, Iran (September 2007 – December 2009)

    • Assisted in courses on Genetics and General Biochemistry

Research Focus: Medical Biotechnology

Mohsen Sheykhhasan’s research in Medical Biotechnology focuses on several areas, including:

  1. Stem Cell Therapy: Particularly interested in the therapeutic applications of mesenchymal stem cells derived from different sources, such as adipose tissue and menstrual blood, for various medical conditions.
  2. Exosome Biology: Investigating the role of exosomes derived from stem cells in modulating gene expression patterns and their potential applications in treating diseases like endometriosis, osteoarthritis, and cancer.
  3. Gene Delivery Systems: Studying innovative approaches for gene delivery using exosomes and other biological vectors to target specific diseases, such as Alzheimer’s disease and acute lymphoblastic leukemia.
  4. Bioinformatics and Molecular Biology: Utilizing bioinformatics tools for gene and protein network analysis in diseases like Crohn’s disease, aiming to understand molecular mechanisms and identify therapeutic targets.

These research areas reflect his dedication to advancing medical biotechnology through innovative therapies and molecular insights.

Citations:

  • Citations: 883 citations from 783 documents.
  • Documents: 59 documents in total.
  • h-index: 18

Publications 📄

  • CAR T Therapies in Multiple Myeloma: Unleashing the Future
    • Published in Cancer Gene Therapy, 2024, 31(5), pp. 667–686.
    • Co-authored with Ahmadieh-Yazdi A., Vicidomini R., Kalhor N., and Dama P.
    • Received 5 citations.
  • Introduction to Neurodegenerative Diseases
    • Book Chapter in Deep Learning Approaches for Early Diagnosis of Neurodegenerative Diseases, 2024, pp. 25–58.
    • Co-authored with Seyedebrahimi R., Yang P., Azimzadeh M., and Kalhor N.
    • Received 1 citation.
  • The Role of Key Biomarkers in Lymphatic Malformation: An Updated Review
    • Published in Journal of Gene Medicine, 2024, 26(2), e3665.
    • Co-authored with Modaghegh M.H.S., Tanzadehpanah H., Kamyar M.M., Lotfian E., and Mahaki H.
    • Received 1 citation.
  • Dual Role of Exosome in Neurodegenerative Diseases: A Review Study
    • Published in Current Stem Cell Research and Therapy, 2024, 19(6), pp. 852–864.
    • Co-authored with Heidari F., Farsani M.E., Ababzadeh S., and Seyedebrahimi R.
    • Received 6 citations.
  • Role of SARS-COV-2 and ACE2 in the Pathophysiology of Peripheral Vascular Diseases
    • Published in Biomedicine and Pharmacotherapy, 2023, 166, 115321.
    • Co-authored with Tanzadehpanah H., Lotfian E., Avan A., Jamshidi R., and Mahaki H.
    • Received 6 citations.
  • Crosstalk Between Long Non-coding RNAs and p53 Signaling Pathway in Colorectal Cancer: A Review Study
    • Published in Pathology Research and Practice, 2023, 249, 154756.
    • Co-authored with Mahdi Khanifar M., Zafari Z., and Sheykhhasan M.
    • Received 8 citations.